These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

669 related items for PubMed ID: 32391796

  • 1. Human exposure to synthetic endocrine disrupting chemicals (S-EDCs) is generally negligible as compared to natural compounds with higher or comparable endocrine activity. How to evaluate the risk of the S-EDCs?
    Autrup H, Barile FA, Berry SC, Blaauboer BJ, Boobis A, Bolt H, Borgert CJ, Dekant W, Dietrich D, Domingo JL, Gori GB, Greim H, Hengstler J, Kacew S, Marquardt H, Pelkonen O, Savolainen K, Heslop-Harrison P, Vermeulen NP.
    Environ Toxicol Pharmacol; 2020 Aug; 78():103396. PubMed ID: 32391796
    [Abstract] [Full Text] [Related]

  • 2. Human exposure to synthetic endocrine disrupting chemicals (S-EDCs) is generally negligible as compared to natural compounds with higher or comparable endocrine activity. How to evaluate the risk of the S-EDCs?
    Autrup H, Barile FA, Berry SC, Blaauboer BJ, Boobis A, Bolt H, Borgert CJ, Dekant W, Dietrich D, Domingo JL, Gori GB, Greim H, Hengstler J, Kacew S, Marquardt H, Pelkonen O, Savolainen K, Heslop-Harrison P, Vermeulen NP.
    Toxicol In Vitro; 2020 Sep; 67():104861. PubMed ID: 32360643
    [Abstract] [Full Text] [Related]

  • 3. Human exposure to synthetic endocrine disrupting chemicals (S-EDCs) is generally negligible as compared to natural compounds with higher or comparable endocrine activity. How to evaluate the risk of the S-EDCs?
    Autrup H, Barile FA, Berry SC, Blaauboer BJ, Boobis A, Bolt H, Borgert CJ, Dekant W, Dietrich D, Domingo JL, Gori GB, Greim H, Hengstler J, Kacew S, Marquardt H, Pelkonen O, Savolainen K, Heslop-Harrison P, Vermeulen NP.
    Chem Biol Interact; 2020 Aug 01; 326():109099. PubMed ID: 32370863
    [Abstract] [Full Text] [Related]

  • 4. Human exposure to synthetic endocrine disrupting chemicals (S-EDCs) is generally negligible as compared to natural compounds with higher or comparable endocrine activity. How to evaluate the risk of the S-EDCs?
    Autrup H, Barile FA, Berry SC, Blaauboer BJ, Boobis A, Bolt H, Borgert CJ, Dekant W, Dietrich D, Domingo JL, Gori GB, Greim H, Hengstler J, Kacew S, Marquardt H, Pelkonen O, Savolainen K, Heslop-Harrison P, Vermeulen NP.
    J Toxicol Environ Health A; 2020 Jul 17; 83(13-14):485-494. PubMed ID: 32552445
    [Abstract] [Full Text] [Related]

  • 5. Human exposure to synthetic endocrine disrupting chemicals (S-EDCs) is generally negligible as compared to natural compounds with higher or comparable endocrine activity. How to evaluate the risk of the S-EDCs?
    Autrup H, Barile FA, Berry SC, Blaauboer BJ, Boobis A, Bolt H, Hengstler J, Borgert CJ, Dekant W, Dietrich D, Domingo JL, Gori GB, Greim H, Kacew S, Marquardt H, Pelkonen O, Savolainen K, Heslop-Harrison P, Vermeulen NP.
    Food Chem Toxicol; 2020 Aug 17; 142():111349. PubMed ID: 32360905
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Editorial on editorial: Human exposure to synthetic endocrine disrupting chemicals (S-EDCs) is generally negligible as compared to natural compounds with higher or comparable endocrine activity. How to evaluate the risk of the S-EDCs?
    Toxicol In Vitro; 2020 Sep 17; 67():104862. PubMed ID: 32360642
    [No Abstract] [Full Text] [Related]

  • 9. Fifteen years after "Wingspread"--environmental endocrine disrupters and human and wildlife health: where we are today and where we need to go.
    Hotchkiss AK, Rider CV, Blystone CR, Wilson VS, Hartig PC, Ankley GT, Foster PM, Gray CL, Gray LE.
    Toxicol Sci; 2008 Oct 17; 105(2):235-59. PubMed ID: 18281716
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Methodological issues in human studies of endocrine disrupting chemicals.
    Lee DH, Jacobs DR.
    Rev Endocr Metab Disord; 2015 Dec 17; 16(4):289-97. PubMed ID: 26880303
    [Abstract] [Full Text] [Related]

  • 13. A proposed framework for the systematic review and integrated assessment (SYRINA) of endocrine disrupting chemicals.
    Vandenberg LN, Ågerstrand M, Beronius A, Beausoleil C, Bergman Å, Bero LA, Bornehag CG, Boyer CS, Cooper GS, Cotgreave I, Gee D, Grandjean P, Guyton KZ, Hass U, Heindel JJ, Jobling S, Kidd KA, Kortenkamp A, Macleod MR, Martin OV, Norinder U, Scheringer M, Thayer KA, Toppari J, Whaley P, Woodruff TJ, Rudén C.
    Environ Health; 2016 Jul 14; 15(1):74. PubMed ID: 27412149
    [Abstract] [Full Text] [Related]

  • 14. Endocrine disrupting chemicals and breast cancer: a systematic review of epidemiological studies.
    Wan MLY, Co VA, El-Nezami H.
    Crit Rev Food Sci Nutr; 2022 Jul 14; 62(24):6549-6576. PubMed ID: 33819127
    [Abstract] [Full Text] [Related]

  • 15. Estrogenic environmental endocrine-disrupting chemical effects on reproductive neuroendocrine function and dysfunction across the life cycle.
    Dickerson SM, Gore AC.
    Rev Endocr Metab Disord; 2007 Jun 14; 8(2):143-59. PubMed ID: 17674209
    [Abstract] [Full Text] [Related]

  • 16. Neuroendocrine and behavioral implications of endocrine disrupting chemicals in quail.
    Ottinger MA, Abdelnabi MA, Henry P, McGary S, Thompson N, Wu JM.
    Horm Behav; 2001 Sep 14; 40(2):234-47. PubMed ID: 11534988
    [Abstract] [Full Text] [Related]

  • 17. Deleterious Biological Effects of Endocrine Disruptors: An Insight into Human Health Risks.
    Al Lawati A, Al Hashmi L, Al Aswami H, Al Hadhrami A, Chin KY, Sirasanagandla SR, Das S.
    Endocr Metab Immune Disord Drug Targets; 2024 Sep 14; 24(13):1471-1479. PubMed ID: 38299284
    [Abstract] [Full Text] [Related]

  • 18. Male pubertal development: are endocrine-disrupting compounds shifting the norms?
    Zawatski W, Lee MM.
    J Endocrinol; 2013 Sep 14; 218(2):R1-12. PubMed ID: 23709001
    [Abstract] [Full Text] [Related]

  • 19. Endocrine Disrupting Chemicals: Current Understanding, New Testing Strategies and Future Research Needs.
    Street ME, Audouze K, Legler J, Sone H, Palanza P.
    Int J Mol Sci; 2021 Jan 19; 22(2):. PubMed ID: 33477789
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 34.